Fig. 1From: Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practiceBiologics survival by Biologic therapy modality: Monotherapy throughout all the course of biologic therapy vs biologic therapy combined with DMARDsBack to article page